X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CARCINOGENESIS

期刊標題檢索 CARCINOGENESIS 最新評論: May I ask what "under review, ED: Not Assigned" means? Why is it sti... (2024-07-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CARCINOGENESIS]您好,您是該頁面的第 78327 位訪客。

期刊簡介
期刊名稱CARCINOGENESIS CARCINOGENESIS
LetPub Score
7.7
50 ratings
Rate

Reputation
8.7

Influence
6.6

Speed
9.2

期刊簡稱CARCINOGENESIS
ISSN0143-3334
E-ISSN1460-2180
h-index189
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.201.0740.729
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q261 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Carcinogenesis: Integrative Cancer Research is a multi-disciplinary journal that brings together all the varied aspects of research that will ultimately lead to the prevention of cancer in man. The journal publishes papers that warrant prompt publication in the areas of Biology, Genetics and Epigenetics (including the processes of promotion, progression, signal transduction, apoptosis, genomic instability, growth factors, cell and molecular biology, mutation, DNA repair, genetics, etc.), Cancer Biomarkers and Molecular Epidemiology (including genetic predisposition to cancer, and epidemiology), Inflammation, Microenvironment and Prevention (including molecular dosimetry, chemoprevention, nutrition and cancer, etc.), and Carcinogenesis (including oncogenes and tumor suppressor genes in carcinogenesis, therapy resistance of solid tumors, cancer mouse models, apoptosis and senescence, novel therapeutic targets and cancer drugs).
官方網站https://academic.oup.com/carcin
在線稿件提交https://mc.manuscriptcentral.com/carcin
開放訪問No
出版商Oxford University Press
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1980
每年文章數86每年文章數趨勢
黃金OA百分比13.47%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2118/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0143-3334%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 33.33%
參考鏈接
相關期刊 【CARCINOGENESIS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS331394
    CANCER RESEARCH312135
    BMC CANCER245650
    Asian Pacific Journal of Cancer Prevention219575
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198017
    INTERNATIONAL JOURNAL OF CANCER191632
    CLINICAL CANCER RESEARCH181667
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176710
    ONCOLOGY REPORTS175034
    CA-A CANCER JOURNAL FOR CLINICIANS163638
  •  

    CARCINOGENESIS CARCINOGENESIS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)
  [CARCINOGENESIS] 的評論撰寫評論
作者: 八极霞姝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-03 20:00:01 評論於
May I ask what "under review, ED: Not Assigned" means? Why is it still under review if the ED has not been assigned?
(0) 讚! | 八极霞姝

作者: 辉夜玄穆


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-03 19:49:09 評論於
We probably didn't find a suitable reviewer, so we are now looking for a new one. Don't worry, this is a normal situation.
(0) 讚! | 辉夜玄穆

作者: 八极霞姝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-03 10:36:36 評論於
Why is it under review, but still ED: Not Assigned?
(0) 讚! | 八极霞姝

作者: 果汁yh


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 17:10:58 評論於
PS can be changed to CMYK mode
(0) 讚! | 果汁yh

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 20:34:42 評論於
The Same Experience
(0) 讚! | 风见凌薇

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 19:13:55 評論於
When can we return to District 2? That molecular carcinogenesis is already in District 2
(0) 讚! | 风见凌薇

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 16:33:56 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Sharing experience: I was fortunate to have one article accepted by this journal. The efficiency of this journal is very high, with the review process starting one week after submission and receiving major revisions within three weeks. The reviewers were satisfied with the overall quality of the article, and the editors were very meticulous in their requirements for figures and tables. The journal's style feels like that of a well-established publication. It is friendly to Chinese authors, fast-paced, and worth recommending more than some other prestigious international journals
(0) 讚! | 风见凌薇

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 13:16:45 評論於
Just posted an article, check it out!
(0) 讚! | 风见凌薇

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 10:59:48 評論於
The external review was sent, but this journal does not have a recommended reviewer process, I think they have their own circle of reviewers
(0) 讚! | 风见凌薇

作者: 风见凌薇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-02 09:27:10 評論於
**

Review Speed: 1.0 | Acceptance Rate: 50.0
Experience Sharing: Frustrated by 10 journals including cancer research, oncogene, cancer letters, finally submitted to this journal. 
18-Mar-2024: Submitted
30-Mar-2024: Major revision
15-Apr-2024: Major revision returned
22-Apr-2024: Accept upon Revision (minor revision)
29-Apr-2024: Minor revision returned
30-Apr-2024: Accept

The speed is not as slow as mentioned in the comments, on the contrary, it is surprisingly fast. Maybe it used to be slow before? Because my article has a large amount of data and is also rigorous, the chief editor found it good and reacted very positively. The reviewers' comments are also nice, no additional experiments were requested, the editor is very detailed in checking the figures and tables. Overall, if you cannot publish in a Tier-1 journal, this longstanding journal can still be considered, and the Chinese are friendly. Hope to return to the 5-star rating!


**
(0) 讚! | 风见凌薇

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 21:50:10 評論於
How to resolve the request for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 21:00:01 評論於
How to solve the issue of CMYK image mode that it requires?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 19:23:45 評論於
How to solve the requirement of CMYK image mode it asks for?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 17:47:34 評論於
How to solve the requirement for CMYK image mode requested by it?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 16:31:19 評論於
How to resolve the requirement for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 15:31:27 評論於
How to address the requirement for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 15:27:09 評論於
How to address the required CMYK image mode for it?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 14:01:55 評論於
Could you please let me know how to deal with the requirement for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 13:19:40 評論於
Could you please tell me how to solve the requirement for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 10:07:14 評論於
How should I handle the request for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 09:48:09 評論於
How to solve the requirement of CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 09:37:42 評論於
How to deal with the required CMYK image mode that it asks for?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 09:09:49 評論於
How to solve the requirement for CMYK image mode?
(0) 讚! | 云居阳煦

作者: 云居阳煦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 08:02:56 評論於
How to resolve the requirement for CMYK image mode that it is asking for?
(0) 讚! | 云居阳煦

作者: 胜平可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-19 20:00:06 評論於
Does this need cell verification?
(0) 讚! | 胜平可爱吗

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)

開始撰寫 [CARCINOGENESIS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*